Alcamí J - Search Results

1

[Conclusions and perspectives. Maraviroc].

Alcamí J. Alcamí J. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 11:49-54. doi: 10.1016/s0213-005x(08)76564-9. Enferm Infecc Microbiol Clin. 2008. PMID: 19133222 Review. Spanish.

2

CCR5 genotype and HIV-1 infection in perinatally-exposed infants.

Mas A, Español T, Heredia A, Pedraza MA, Hernandez M, Caragol I, Fernando M, Bertran JM, Alcami J, Soriano V. Mas A, et al. Among authors: alcami j. J Infect. 1999 Jan;38(1):9-11. doi: 10.1016/s0163-4453(99)90020-8. J Infect. 1999. PMID: 10090498

3

Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection.

Mañes S, del Real G, Lacalle RA, Lucas P, Gómez-Moutón C, Sánchez-Palomino S, Delgado R, Alcamí J, Mira E, Martínez-A C. Mañes S, et al. Among authors: alcami j. EMBO Rep. 2000 Aug;1(2):190-6. doi: 10.1093/embo-reports/kvd025. EMBO Rep. 2000. PMID: 11265761 Free PMC article.

4

[Antiretroviral resistance testing. A necessary element in the follow-up of the HIV-infected patient].

Alcamí J, Rubio R. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):1-2. Enferm Infecc Microbiol Clin. 2001. PMID: 11428052 Spanish. No abstract available.

5

[Biological basis for generating resistance to antiretroviral drugs].

Alcamí J, Delgado R, Menéndez-Arias L. Alcamí J, et al. Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):3-13. Enferm Infecc Microbiol Clin. 2001. PMID: 11428056 Review. Spanish. No abstract available.

6

[GESIDA Consensus document on the use of resistance studies in clinical practice].

Gatell JM, Blanco JL, Alcamí J, Antela A, Arrizabalaga J, Casado JL, Clotet B, Delgado R, Erice A, Guerra L, Guerrero A, Iribarren JA, Leal M, López JC, Menéndez-Arias L, Miró JM, Moreno S, Pérez JL, Pumarola T, Rubio R, Ruiz L, Santamaría JM, Soriano V, Telenti A, Viciana P. Gatell JM, et al. Among authors: alcami j. Enferm Infecc Microbiol Clin. 2001 Feb;19(Monografico):53-60. Enferm Infecc Microbiol Clin. 2001. PMID: 11428062 Review. Spanish. No abstract available.

7

[Present situation regarding development of an HIV vaccine].

Alcami J. Alcami J. Enferm Infecc Microbiol Clin. 2002 Dec;20(10):511-22. doi: 10.1016/s0213-005x(02)72855-3. Enferm Infecc Microbiol Clin. 2002. PMID: 12433353 Review. Spanish.

8

Dynamics of HIV replication in lymphocytes and the efficacy of protease inhibitors.

Bermejo M, Sánchez-Palomino S, Usán L, Alcamí J. Bermejo M, et al. Among authors: alcami j. J Med Virol. 2004 Aug;73(4):502-7. doi: 10.1002/jmv.20118. J Med Virol. 2004. PMID: 15221892

9

Prostratin induces HIV activation and downregulates HIV receptors in peripheral blood lymphocytes.

Rullas J, Bermejo M, García-Pérez J, Beltán M, González N, Hezareh M, Brown SJ, Alcamí J. Rullas J, et al. Among authors: alcami j. Antivir Ther. 2004 Aug;9(4):545-54. Antivir Ther. 2004. PMID: 15456086

10

[Advances in the immunopathology of HIV infection].

Alcamí J. Alcamí J. Enferm Infecc Microbiol Clin. 2004 Oct;22(8):486-96. doi: 10.1016/s0213-005x(04)73144-4. Enferm Infecc Microbiol Clin. 2004. PMID: 15482691 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results